GlassScriptPhysician profile
Michelle Spector
NPI 1376528265
$1,018.14
in general payments reported to CMS, 2019-2025
17 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $78.99 · 2021: $14.81 · 2022: $93.51 · 2023: $191 · 2024: $137 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $304.45 | 2022-2025 | Veozah |
| Abbvie INC. | $178.11 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $89.68 | 2019-2023 | |
| Pfizer INC. | $85.12 | 2019-2024 | |
| Smith+Nephew, INC. | $78.31 | 2019 | |
| Avion Pharmaceuticals | $51.54 | 2019-2022 | |
| Therapeuticsmd, INC. | $36.81 | 2019-2020 | |
| Coopersurgical, INC. | $23.96 | 2024 | Paragard T 380a |
| Duchesnay USA Incorporated | $23.81 | 2019 | |
| Aspira Women'S Health INC | $22.09 | 2020 | |
| Seqirus USA INC | $21.22 | 2025 | Fluad, Flucelvax |
| Roche Diagnostics Corporation | $20.02 | 2019 | |
| Millicent US INC | $18.52 | 2023 | Femring, Intrarosa |
| Ferring Pharmaceuticals INC. | $17.49 | 2019 | |
| Merck Sharp & Dohme LLC | $16.10 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.65 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Spector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.